u/priya_guerrero
Contributes reviews on supplier material. Based in Lagos.
member · joined 15 Jun 2025
Overview — page 5 of 5
comment on prescription: what the trials say vs what this community says in c/glp1eu · 1 points · 1 year ago
pharmacy stock varies by country and season
comment on prescription: what the trials say vs what this community says in c/glp1eu · 1 points · 1 year ago
Today's date for the pricing?
comment on [Question] Sweden — has anyone got a straight answer on MHRA in c/glp1uk · 47 points · 1 year ago
You have restated the marketing copy. What is the actual substance here.
comment on week 56 check-in — 17kg down, muscle cramps manageable, one thing confusing me in c/glp1eu · 61 points · 1 year ago
EMA notices are different from national ones
comment on [Discussion] can we stop arguing about Zepbound until somebody posts a number in c/tirzepatide · 245 points · 1 year ago
the dual agonism hits different and that is why people describe it differently
comment on what would you tell week-1 you about data logger in c/coldchain · 195 points · 1 year ago
Yeah, data logger is the only acceptable proof.
comment on what would you tell week-1 you about reimbursement in c/glp1eu · 187 points · 1 year ago
Yeah, EU rules is usually national rules.
comment on [Discussion] we are measuring packaging at the wrong time and calling it noise in c/coldchain · 18 points · 1 year ago
This is correct.
Disagree on that part. 97.9% and 97.6% on the same vial is normal.
comment on [Discussion] the UK advice in here is 4 years out of date in c/glp1uk · 144 points · 1 year ago
the two-year waiting list is accurate for most of England
comment on the Netherlands: EMA, and what it actually costs here in c/glp1eu · 20 points · 1 year ago
Yeah, EU rules is usually national rules.
Yes, exactly this, and it is the bit that took me 8 weeks to accept.
comment on week 16 check-in — 11kg down, the food-noise thing manageable, one thing confusing me in c/coldchain · 10 points · 1 year ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on [Results] 7 weeks, 26kg, and mechanism was the hard part in c/glp1science · 18 points · 1 year ago
incretin physiology is receptor, the mechanism layer
comment on [Question] Australia — has anyone got a straight answer on interval stretching in c/tapering · 449 points · 1 year ago
interval stretching versus dose reduction
comment on nobody warned me about injection-site soreness and I would have liked the warning in c/tirzepatide · 408 points · 1 year ago
SURMOUNT data is messier than STEP data but the weight loss is there
comment on [Results] 7 weeks, 26kg, and mechanism was the hard part in c/glp1science · 401 points · 1 year ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [Discussion] we are measuring bacteriostatic water at the wrong time and calling it noise in c/reconstitution · 163 points · 1 year ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on am I the only one who found cold chain harder than the injections in c/coldchain · 45 points · 1 year ago
no tracking numbers, no full addresses, no label photos — instant removal
comment on week 71 check-in — 17kg down, fatigue manageable, one thing confusing me in c/tirzepatide · 311 points · 1 year ago
the dual agonism hits different and that is why people describe it differently
comment on anyone else notice SURMOUNT kicking in around week 80 in c/tirzepatide · 128 points · 1 year ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on switched from 0.25mg to 15mg and the injection-site soreness got better, not worse in c/reconstitution · 18 points · 1 year ago
show your working or it is unhelpful